Literature DB >> 14636315

Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.

James P Stables1, Ed Bertram, F E Dudek, Greg Holmes, Gary Mathern, Asla Pitkanen, H S White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14636315     DOI： 10.1111/j.0013-9580.2003.32803.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  37 in total

1.  Is neuronal death necessary for acquired epileptogenesis in the immature brain?

Authors:  F Edward Dudek; Jeffrey J Ekstrand; Kevin J Staley
Journal:  Epilepsy Curr       Date:  2010-07       Impact factor: 7.500

Review 2.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Discovery of antiepileptic drugs.

Authors:  Misty Smith; Karen S Wilcox; H Steve White
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

4.  The best model for a cat is the same cat...or is it?

Authors:  Andrey Mazarati
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

5.  New developments in antiepileptic drug resistance: an integrative view.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2009 Mar-Apr       Impact factor: 7.500

6.  In search of a new and improved target for antiepileptic drugs: sialic acid?

Authors:  F Edward Dudek; Edward H Bertram
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

7.  Elemental anomalies in the hippocampal formation after repetitive electrical stimulation: an X-ray fluorescence microscopy study.

Authors:  J Chwiej; H Gabrys; K Janeczko; J Kutorasinska; K Gzielo-Jurek; K Matusiak; K Appel; Z Setkowicz
Journal:  J Biol Inorg Chem       Date:  2014-07-16       Impact factor: 3.358

Review 8.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

9.  Modulation of sodium channel inactivation gating by a novel lactam: implications for seizure suppression in chronic limbic epilepsy.

Authors:  Paulianda J Jones; Ellen C Merrick; Timothy W Batts; Nicholas J Hargus; Yuesheng Wang; James P Stables; Edward H Bertram; Milton L Brown; Manoj K Patel
Journal:  J Pharmacol Exp Ther       Date:  2008-10-24       Impact factor: 4.030

10.  Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.

Authors:  Ajay K Srivastava; H Steve White
Journal:  Epilepsy Res       Date:  2012-11-14       Impact factor: 3.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.